AdiMap
Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.
About
Adimab is a premier antibody discovery and engineering platform that delivers therapeutic proteins, including IgGs, HCAbs, multispecifics, and TCRs, from concept to clinic. Their proprietary yeast-based platform enables the efficient discovery and engineering of highly specific, stable, and developable antibody candidates. Adimab partners with biopharma companies to advance therapeutic programs and improve patient outcomes. Teams look it up for Fintech, Trading, Intelligence.
Frequently asked
What does AdiMap do?
AdiMap is a Fintech company that offers Software. Teams look it up for Trading, Intelligence, Data Science. It is based in Lebanon, United States and was founded in 2010. Public records show about 139 people and $105M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has AdiMap raised?
AdiMap has raised a total of $105M in funding. The most recent round on record is Series B.
Where is AdiMap headquartered?
AdiMap is headquartered in Lebanon, United States.
When was AdiMap founded?
AdiMap was founded in 2010.
What industry does AdiMap operate in?
AdiMap operates in Fintech, Trading, Intelligence, Data Science, Financial Graph.
How many employees does AdiMap have?
AdiMap has approximately 139 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.